Pfizer, Genmab’s ADC Tivdak Scores Full FDA Approval in Recurrent or Metastat...
Pictued: Pfizer sign at its world headquarters in New York/iStock, JHVEPhoto The FDA on Monday granted full approval to Pfizer and Genmab’s antibody-drug conjugate Tivdak (tisotumab vedotin-tftv) for the treatment of recurrent or metastatic cervical …